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We also fitted a Cox model with time-dependent covariates using the same 206 covariates as Model 4 and using the same timespan and number of events (Model 207 5). All survival models used age as the time scale (21, 22) . For the Cox models, 208 those developing CVD before R3 were excluded. For the joint models information 209 available after an individual developed CVD was not used. Prevalent cases of CVD 210 at the first examination (2.18%, N=83) were excluded from the analyses. Prediction models 1-5 were discriminated using the C-index (23) and net 215 reclassification index (NRI) (24) using the 10 year probabilities of CVD derived from 216 the models using round 3 as the baseline. Ten-fold cross validation was used to 217 adjust the risk estimates for over optimism in assessing model performance on the 218 same dataset where it was developed (25, 26). The analyses were carried out in 219 both genders combined, and performed using R v3.1.1 (R Core Team (2013) (27).
220
Our study conforms to TRIPOD guidelines for reporting prediction models (28). 
Results

224
( Supplemental table 7) . None of the models incorporating change in hs-cTnI 300 improved prediction when compared to the model with a single measure of hs-cTnI 301 at round 3. ( Supplemental Table 7 ). See Supplemental methods for further details. became the starting point for predictions. Our study had longer intervals of 313 measurement than comparable studies (9, 10) and with larger number of events (9) 314 and we used a joint modelling (JM) approach which more sensitively monitored the 315 change in hs-cTnI (M4) than incorporating change as a predictor in the models (M3). 316 We found that hs-cTnI increases over time in the general population and the change 317 in hs-cTnI is associated with increased risk of fatal and non-fatal CVD. Our findings 318 applied across a wide age range including a younger group, while previous findings 319 for association of change in hs-cTnI or hs-cTnT with increased risk of heart failure, 320 cardiovascular death and all-cause mortality are evident in older groups (>65 years) 321 (9, 10) and a middle-aged group for coronary heart disease (13).We found three Longitudinal submodel for hs-cTnI (from the joint model).
573
Survival submodel (from the joint model).
574 Table 4 Risk models describing the improvement of 10-year risk prediction for 575 cardiovascular disease by high sensitivity troponin I in all participants. 
